Loading...
XSHG
600421
Market cap141mUSD
Apr 08, Last price  
5.29CNY
1D
-7.52%
1Q
-19.85%
Name

Hubei Huarong Holding Co Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
8.47
EPS
—
Div Yield, %
—
Shrs. gr., 5y
2.99%
Rev. gr., 5y
161.29%
Revenues
122m
-2.45%
201,066,931196,893,290298,182,30818,142,93919,130,84318,936,64214,281,20710,756,2208,037,0408,368,91644,112,97127,852,36528,177,07928,767,3091,002,70423,267,767140,188,499130,352,941125,191,438122,123,443
Net income
-8m
27,279,66416,369,88615,314,9290054,812,08600119,748,05113,797,5362,169,673186,9243,210,023003,263,81715,407,97600-8,279,504
CFO
6m
0016,033,0460070,242,35166,210069,315,04801,966,64500006,097,9250006,016,092
Earnings
May 23, 2025

Profile

Hubei Huarong Holding Co.,Ltd. produces and distributes pharmaceutical products in China. The company's principal pharmaceutical products include Gucining Capsules and Huoxue Tongmai Capsules. It also develops biological products, pharmaceuticals, environment-protection, and agricultural products, as well as related technologies. The company was formerly known as Hubei Yangfan Holding Co., Ltd. and changed its name to Hubei Huarong Holding Co.,Ltd. in November 2020. Hubei Huarong Holding Co.,Ltd. was founded in 1997 and is headquartered in Wuhan, China.
URL
spring.com.cn
IPO date
Jun 07, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
122,123
-2.45%
125,191
-3.96%
Cost of revenue
113,926
123,538
Unusual Expense (Income)
NOPBT
8,198
1,653
NOPBT Margin
6.71%
1.32%
Operating Taxes
1,069
Tax Rate
13.03%
NOPAT
7,129
1,653
Net income
(8,280)
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
53,982
16,272
Long-term debt
5,735
7,434
Deferred revenue
234
343
Other long-term liabilities
800
800
Net debt
56,037
6,337
Cash flow
Cash from operating activities
6,016
CAPEX
Cash from investing activities
(16,967)
Cash from financing activities
10,914
14,239
FCF
(26,898)
133
Balance
Cash
3,680
3,704
Long term investments
1
13,664
Excess cash
11,109
Stockholders' equity
(156,183)
282,379
Invested Capital
253,434
51,418
ROIC
4.68%
3.51%
ROCE
8.37%
2.64%
EV
Common stock shares outstanding
206,988
195,600
Price
11.13
3.15%
10.79
12.63%
Market cap
2,303,772
9.16%
2,110,524
12.63%
EV
2,386,377
2,142,214
EBITDA
13,172
7,128
EV/EBITDA
181.17
300.52
Interest
2,628
1,030
Interest/NOPBT
32.06%
62.31%